Business context and reporting period
Entity mismatch: The request identifies BONK, INC., but the supplied filing is Safety Shot, Inc.’s Form 10-Q (formerly Jupiter Wellness, Inc.), trading as SHOT. It covers the quarter and nine months ended September 30, 2023; the financial statements are unaudited. The company acquired certain Safety Shot product assets in August 2023 and said it planned a 2024 product rollout. It also spun off control of SRM Entertainment in August and retained a minority investment.
Financial performance and position
| Metric | Q3 2023 | Q3 2022 | Nine months 2023 | Nine months 2022 |
|---|---|---|---|---|
| Revenue | $484,196 | $1,568,925 | $3,971,130 | $5,291,136 |
| Gross profit | $58,384 | $413,308 | $808,778 | $1,035,762 |
| Gross margin | 12.1% | 26.3% | 20.4% | 19.6% |
| Operating expenses | $4,182,558 | $2,196,502 | $7,677,796 | $6,610,585 |
| Net loss | $(7,738,301) | $(2,332,426) | $(9,406,066) | $(6,692,957) |
| Basic loss per share | $(0.26) | $(0.10) | $(0.34) | $(0.30) |
Q3 revenue fell about 69% year over year; nine-month revenue fell about 25%. Nine-month operating cash use was $5.03 million, compared with $4.75 million in the prior-year period. Cash increased by $2.46 million over the nine months, principally reflecting $6.79 million of cash proceeds from share issuance and warrant exercises, partly offset by operating and other uses.
At September 30, 2023, cash was $4.39 million and marketable securities were $2.28 million. Current assets were $8.17 million against current liabilities of $4.26 million, implying working capital of $3.90 million. Total assets were $11.33 million, total liabilities $4.62 million, and shareholders’ equity $6.71 million. The company reported $2.00 million of convertible notes, bearing 8% interest and due January 31, 2024, plus a $49,166 SBA loan balance. Lease liabilities totaled approximately $565,000.
Material changes, outlook, and risks
- Q3 net loss widened substantially as lower revenue and gross profit coincided with higher operating costs and other expenses. Nine-month general and administrative expense was $3.02 million, legal and professional expense $2.61 million, and stock-based compensation $1.47 million.
- Other items affecting results included a $409,549 loss on SRM deconsolidation, a $726,884 loss recognized on the SRM equity-method investment, and a $1.12 million debt-extinguishment loss from amendments that reduced conversion and warrant exercise prices. The Q3 statement also reports $2.43 million of “other income/(expense),” but the filing text does not provide a clear explanation of that amount.
- The GBB asset purchase was recorded as $2.67 million of patents, paid with $200,000 cash and 5.0 million restricted shares. The patents are to be amortized over 12 years. The company’s reported shares outstanding rose from 22.34 million at December 2022 to 37.21 million at September 2023; 39.82 million were outstanding November 13. A further 2.61 million shares were issued upon warrant conversion after quarter-end.
- Management stated that the company planned to launch Safety Shot online and through Amazon, with Big Box store plans for 2024. It also described licensing plans for JW-700 and other wellness products. No quantified revenue, earnings, cash-flow, or launch targets were provided. The product’s stated blood-alcohol-related benefit is a company description, not an independently verified result in this filing.
- The company disclosed substantial accumulated deficits and operating cash use, and stated these conditions raise doubt about its ability to continue as a going concern. It expects significant costs to continue in pursuit of expansion and development.
- Management concluded disclosure controls were ineffective, citing the number and magnitude of adjustments made by external auditors and limitations in the current small-team control process. It described remediation efforts, including hiring personnel with internal-control experience and improving accounting processes.
- Management reported no pending or threatened litigation it believed would materially harm its financial position, results, or liquidity. A previously disclosed dispute was settled and dismissed without a settlement payment. The filing identifies the notes as related-party debt; investors should review the related-party terms and the CEO’s investment-related bonus arrangement.
Most important facts to verify
- Confirm the filing’s issuer and ticker: the supplied document is for Safety Shot, Inc. (SHOT), not BONK, INC.
- Review the going-concern disclosure, cash burn, and ability to repay or refinance the $2.00 million convertible notes due January 31, 2024.
- Reconcile the Q3 $2.43 million “other income/(expense)” line and assess the valuation and liquidity of the Chijet marketable securities.
- Assess dilution from issued shares, outstanding warrants and options, and post-quarter warrant conversions.
- Evaluate the basis and evidence for Safety Shot’s product claims, launch timing, regulatory status, and expected commercialization costs.
- Track remediation of ineffective disclosure controls and verify future reporting reliability.